India’s ayurveda and herbal wellness market is booming, and one startup is riding the wave with unmatched momentum. Kapiva, a leading ayurvedic wellness brand, has just raised $60 million in its latest funding round to fuel research, brand building, and global expansion—cementing its position as a frontrunner in India’s fast-growing wellness ecosystem.

---

Funding Details: How Kapiva Sealed $60 Million

The fresh capital includes:

• $28 million in primary capital for growth initiatives
• $32 million in secondary transactions, allowing early investors, including Fireside Ventures, to partially exit

The round kicked off in September 2024 with a $10 million infusion from OrbiMed Asia, Vertex Ventures, and 3one4 Capital. With this latest round, Kapiva has raised nearly $90 million since inception, including roughly Rs 300 crore in secondary share sales.

---

Kapiva’s Mission: Ayurveda Meets Modern Wellness

Founded in 2015 by Ameve Sharma and Shrey Badhani, Kapiva offers an extensive portfolio of ayurvedic nutrition products spanning supplements, gummies, capsules, skincare, and health consultations with Ayurvedic doctors. With 100+ SKUs, the brand aims to make natural wellness accessible and effective for modern lifestyles.

According to Sharma, the new funds will be used to:

• Invest in research and development for next-generation ayurvedic products
• Strengthen manufacturing capabilities for scale and quality
• Accelerate brand-building and marketing to reach wider audiences
• Expand its health-tech platform for chronic condition management and personalized care
• Drive international growth, targeting markets in the UK, US, and UAE, where 5–10% of revenue already comes from

---

Distribution & Growth: From India to the World

Kapiva’s products are now available in 40,000 offline retail stores across India, in addition to its ecommerce platform and own website. The startup is seeing rapid traction, with an annual revenue run rate of Rs 550 crore, up from Rs 350 crore in FY25, and a consistent 80% year-on-year growth over the past three years.

With global health and wellness trends favoring herbal and natural products, Kapiva is positioned to leverage both domestic and international demand.

---

The Market Opportunity

The ayurvedic and herbal wellness market in India is projected to reach Rs 3.21 lakh crore by 2032, growing at a CAGR of 17% from 2024. Consumer appetite for natural and herbal products spans multiple categories—from skincare and personal care to functional beverages and dietary supplements.

Kapiva, with its diverse product range, trusted brand, and tech-enabled wellness solutions, is perfectly poised to capture a significant share of this growing market.

---

Why Investors Are Betting on Kapiva

Kapiva represents the intersection of ancient wisdom and modern technology—a combination that appeals to both investors and consumers. Its growth strategy balances:

• Product innovation (100+ SKUs and new R&D)
• Digital health-tech solutions for chronic care
• Offline and online distribution at scale
• International expansion to high-value markets

According to investors, the brand’s strong revenue growth, loyal consumer base, and international aspirations make it a compelling bet in India’s booming wellness space.

---

What’s Next for Kapiva?

With $60 million in fresh capital, Kapiva is gearing up to:

1. Develop breakthrough ayurvedic products that blend traditional remedies with modern science
2. Expand its health-tech platform, offering personalized wellness plans and chronic condition management
3. Enhance its brand presence both in India and globally
4. Scale manufacturing to meet growing demand efficiently

In short, Kapiva is not just selling wellness—it’s building a global ayurveda ecosystem.

---